Literature DB >> 30902421

Ultrasound Elastography to Quantify Liver Disease Severity in Autosomal Recessive Polycystic Kidney Disease.

Erum A Hartung1, Jessica Wen2, Laura Poznick3, Susan L Furth4, Kassa Darge5.   

Abstract

OBJECTIVES: To evaluate the diagnostic accuracy of ultrasound elastography with acoustic radiation force impulse (ARFI) to detect congenital hepatic fibrosis and portal hypertension in children with autosomal recessive polycystic kidney disease (ARPKD). STUDY
DESIGN: Cross-sectional study of 25 children with ARPKD and 24 healthy controls. Ultrasound ARFI elastography (Acuson S3000, Siemens Medical Solutions USA, Inc, Malvern, Pennsylvania) was performed to measure shear wave speed (SWS) in the right and left liver lobes and the spleen. Liver and spleen SWS were compared in controls vs ARPKD, and ARPKD without vs with portal hypertension. Linear correlations between liver and spleen SWS, spleen length, and platelet counts were analyzed. Receiver operating characteristic analysis was used to evaluate diagnostic accuracy of ultrasound ARFI elastography.
RESULTS: Participants with ARPKD had significantly higher median liver and spleen SWS than controls. At a proposed SWS cut-off value of 1.56 m/s, the left liver lobe had the highest sensitivity (92%) and specificity (96%) for distinguishing participants with ARPKD from controls (receiver operating characteristic area 0.92; 95% CI 0.82-1.00). Participants with ARPKD with portal hypertension (splenomegaly and low platelet counts) had significantly higher median liver and spleen stiffness than those without portal hypertension. The left liver lobe also had the highest sensitivity and specificity for distinguishing subjects with ARPKD with portal hypertension.
CONCLUSIONS: Ultrasound ARFI elastography of the liver and spleen, particularly of the left liver lobe, is a useful noninvasive biomarker to detect and quantify liver fibrosis and portal hypertension in children with ARPKD.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congenital hepatic fibrosis; pediatrics; portal hypertension; shear wave elastography

Mesh:

Year:  2019        PMID: 30902421      PMCID: PMC6535353          DOI: 10.1016/j.jpeds.2019.01.055

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  24 in total

1.  Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection.

Authors:  Sebastian Kummer; Abdurrahman Sagir; Simone Pandey; Markus Feldkötter; Sandra Habbig; Friederike Körber; Dietrich Ney; Bernd Hoppe; Dieter Häussinger; Ertan Mayatepek; Jun Oh
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

2.  Acoustic radiation force impulse-imaging in the assessment of liver fibrosis in children.

Authors:  Maria José Noruegas; Hugo Matos; Isabel Gonçalves; Maria Augusta Cipriano; Conceição Sanches
Journal:  Pediatr Radiol       Date:  2011-10-15

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver.

Authors:  Takeo Toshima; Ken Shirabe; Kazuki Takeishi; Takashi Motomura; Youhei Mano; Hideaki Uchiyama; Tomoharu Yoshizumi; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

5.  Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis.

Authors:  M Friedrich-Rust; J Nierhoff; M Lupsor; I Sporea; C Fierbinteanu-Braticevici; D Strobel; H Takahashi; M Yoneda; T Suda; S Zeuzem; E Herrmann
Journal:  J Viral Hepat       Date:  2011-10-30       Impact factor: 3.728

6.  Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.

Authors:  Rhona Capisonda; Veronique Phan; Jeffrey Traubuci; Alan Daneman; J Williamson Balfe; Lisa M Guay-Woodford
Journal:  Pediatr Nephrol       Date:  2003-01-21       Impact factor: 3.714

7.  Autosomal recessive polycystic kidney disease: the clinical experience in North America.

Authors:  Lisa M Guay-Woodford; Renee A Desmond
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

8.  Spleen length in childhood with US: normal values based on age, sex, and somatometric parameters.

Authors:  Stylianos D Megremis; Ioannis G Vlachonikolis; Amalia M Tsilimigaki
Journal:  Radiology       Date:  2004-02-27       Impact factor: 11.105

9.  Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).

Authors:  Magdalena Adeva; Mounif El-Youssef; Sandro Rossetti; Patrick S Kamath; Vickie Kubly; Mark B Consugar; Dawn M Milliner; Bernard F King; Vicente E Torres; Peter C Harris
Journal:  Medicine (Baltimore)       Date:  2006-01       Impact factor: 1.889

10.  New equations to estimate GFR in children with CKD.

Authors:  George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

View more
  4 in total

Review 1.  Fibrocystic liver disease: novel concepts and translational perspectives.

Authors:  Alberto Lasagni; Massimiliano Cadamuro; Giovanni Morana; Luca Fabris; Mario Strazzabosco
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

2.  Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.

Authors:  Lindsay T Fleischer; Lance Ballester; Mohini Dutt; Kathryn Howarth; Laura Poznick; Kassa Darge; Susan L Furth; Erum A Hartung
Journal:  J Nephrol       Date:  2022-08-18       Impact factor: 4.393

3.  Magnetic resonance elastography to quantify liver disease severity in autosomal recessive polycystic kidney disease.

Authors:  Erum A Hartung; Juan S Calle-Toro; Carolina Maya Lopera; Jessica Wen; Robert H Carson; Mohini Dutt; Kathryn Howarth; Susan L Furth; Kassa Darge; Suraj D Serai
Journal:  Abdom Radiol (NY)       Date:  2020-08-05

Review 4.  Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.

Authors:  Eric G Benz; Erum A Hartung
Journal:  Pediatr Nephrol       Date:  2021-01-21       Impact factor: 3.651

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.